Skip To Content

Error

Sorry, the page you're looking for has moved or doesn't exist.

You can access content using the navigation or using the search function.

Articles and blogs 

September 01, 2023 · Clinical Team
Earlier this year, the American Geriatrics Society (AGS) published an update to the AGS Beers Criteria® for potentially inappropriate medication (PIM) use in older adults (65 years of age and older). Older adults are more likely to experience unwanted adverse effects and be more sensitive to certain medications. Read more...
August 23, 2023 · Medicare Insights Team
On August 8, the Center for Medicare & Medicaid Services (CMS) released an updated Non-Group Health Plan (NGHP) User Guide, Version 7.2, which includes important updates. Read more...
August 11, 2023 · Clinical Team
FDA approves additional over-the-counter naloxone products Read more...
July 18, 2023 · Clinical Team
The 2Q 2023 Brand-Generic Pipeline update Read more...
July 06, 2023 · Clinical Team
Extended-release Brixadi has been approved by the FDA for subcutaneous injection in patients recovering from Opioid Use Disorder as part of their treatment plan. Read more...
June 13, 2023 · Medicare Insights Team
On June 6, the Center for Medicare & Medicaid Services (CMS) released an updated Non-Group Health Plan (NGHP) User Guide, Version 7.2, which includes important changes. Read more...
May 22, 2023 · Public Policy & Regulatory Affairs Team
In Episode #20,  the Policy Guys visit with Andrew Sabolic, former Deputy Director at Florida’s Division of Workers’ Compensation and current Executive Director at WCI for an in-depth discussion about the workers’ comp regulations – how they are formulated, refined and written into law, as well as useful tips on how best to work with state regulators. Read more...
May 19, 2023 · Medicare Insights Team
The Centers for Medicare and Medicaid Services (CMS) released an updated Workers’ Compensation Medicare Set Aside (WCMSA) Reference Guide, version 3.9, dated 5/15/2023, which includes two significant changes. Read more...
May 18, 2023 · Medicare Insights Team
On April 27, 2023, CMS released the NGHP Applicable Plan Appeals Reference Guide as a way to streamline the appeal process, which includes types of appeals and documentation needed to support appeals. Read more...
May 08, 2023 · Clinical Team
The U.S. Food and Drug Administration (FDA) announced that Teva Pharmaceuticals USA voluntarily recalled specific lots of various strengths of fentanyl buccal tablets at the consumer level. Read more...
<< Previous      Next >>
Page 3 of 15